Back

Novel first-in-class drug candidate protects from ischemia-reperfusion injury by targeting the SERCA2 complex

31 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Innovative therapeutic strategies to combat ischaemia-reperfusion injury and cardiac dysfunction Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Ana Calejo

Serca Pharmaceuticals, Oslo (Norway)

6 More presentations in this session

Presentation thumbnail
PPAR alpha-driven CISD2 upregulation by hesperetin protects against myocardial ischemia/reperfusion injury
Professor C. Yeh (Tao-Yuan, TW)
Abstract Slides Video
Presentation thumbnail
Empagliflozin preserves hemodynamics and left ventricular function in nephrectomized rats after ischemia-reperfusion injury: a potential direct cardioprotective effect of SGLT2 inhibitor
Doctor K. Akiyoshi (Kasukabe, JP)
Abstract Slides Video
Presentation thumbnail
Organic polydopamine nanoparticles ameliorate endothelial ischemia-reperfusion injury, increasing antioxidant defense and reducing inflammatory response
Doctor S. Babboni (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Activation of AMPK via inhibition of PAR2 limits myocardial ischemia-reperfusion injury
Doctor L. Li (Winnipeg, CA)
Abstract Slides Video
Presentation thumbnail
Mitochondria-targeted Hydrogen Sulfide exerts protective effects and maintains mitochondria homeostasis against ischemia reperfusion injury in heart transplantation via the mitofusion-1 pathway
Doctor C. Zhu (Changchun, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Innovative therapeutic strategies to combat ischaemia-reperfusion injury and cardiac dysfunction

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
ND-13 preserves mitochondrial integrity via the RhoA/ROCK1/Drp1-S616 pathway providing acute cardioprotection in myocardial infarction
thumbnail
Congress Session
Untapped and forgotten: controversies in the treatment of ischaemia-reperfusion injury
thumbnail
Congress Presentation
Past agents that missed the mark

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources